Cargando…

Discontinuation, persistence and adherence to subcutaneous biologics delivered via a homecare route to Scottish adults with rheumatic diseases: a retrospective study

OBJECTIVES: To understand patterns of subcutaneous (SC) biologics use over time in adults with inflammatory rheumatic musculoskeletal diseases receiving a homecare delivery service. DESIGN: Retrospective cohort. SETTING: Patients in secondary care receiving SC biologics in the largest Scottish Healt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alvarez-Madrazo, Samantha, Kavanagh, Kimberley, Siebert, Stefan, Semple, Yvonne, Godman, Brian, Maciel Almeida, Alessandra, Acurcio, Francisco de Assis, Bennie, Marion
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Rheumatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731860/ https://www.ncbi.nlm.nih.gov/pubmed/31488467 http://dx.doi.org/10.1136/bmjopen-2018-027059

Ejemplares similares

Adherence and persistence of subcutaneous biologics delivered through homecare services to a cohort of patients with rheumatoid arthritis
por: Alvarez-Madrazo, Samantha, et al.
Publicado: (2017)

Protocol for a multicentre randomised controlled parallel-group trial to compare the effectiveness of remotely delivered cognitive-behavioural and graded exercise interventions with usual care alone to lessen the impact of fatigue in inflammatory rheumatic diseases (LIFT)
por: Martin, Kathryn R, et al.
Publicado: (2019)

Impact of Rheumatic Diseases on Oral Health-Related Quality of Life
por: Aloyouny, Ashwag Y, et al.
Publicado: (2022)

Tocilizumab in Large Vessel Vasculitis – Different Routes of Administration
por: Schmalzing, Marc, et al.
Publicado: (2018)

Discontinuation of tofacitinib and TNF inhibitors in patients with rheumatoid arthritis: analysis of pooled data from two registries in Canada
por: Movahedi, Mohammad, et al.
Publicado: (2023)

Patient and parent perspectives on transition from paediatric to adult healthcare in rheumatic diseases: an interview study
por: Jiang, Ivy, et al.
Publicado: (2021)

Characteristics of Late-Onset Spondyloarthritis: Data from the Moroccan Registry of Biological Therapies in Rheumatic Diseases
por: Mougui, Ahmed, et al.
Publicado: (2023)

Inequity and vulnerability in Latin American Indigenous and non-Indigenous populations with rheumatic diseases: a syndemic approach
por: Granados, Ysabel, et al.
Publicado: (2023)

Identification of new biomarkers to promote personalised treatment of patients with inflammatory rheumatic disease: protocol for an open cohort study
por: Kringelbach, Tina Marie, et al.
Publicado: (2018)

Psychometric evaluation of the Arthritis Self-Efficacy Scale in Chinese adults with rheumatic diseases: a cross-sectional study
por: Tsai, Tzung-Yi, et al.
Publicado: (2021)

NET-RMDs study: networks of fatigue and pain in rheumatic and musculoskeletal diseases – protocol for an international cross-sectional study
por: Gavilán-Carrera, Blanca, et al.
Publicado: (2022)

The Efficacy and Safety of Subcutaneous Ixekizumab for the Treatment of Axial Spondylarthritis: A Systematic Review and Meta-Analysis
por: Alzahrani, Ziyad, et al.
Publicado: (2023)

Use of prescription opioids among patients with rheumatic diseases compared to patients with hypertension in the USA: a retrospective cohort study
por: Chen, Sarah K, et al.
Publicado: (2019)

Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review
por: Luttropp, Karin, et al.
Publicado: (2019)

Hand-related physical function in rheumatic hand conditions: a protocol for developing a patient-reported outcome measurement instrument
por: Klokker, Louise, et al.
Publicado: (2016)

Impact of COVID-19 pandemic social restriction measures on people with rheumatic and musculoskeletal diseases in the UK: a mixed-methods study
por: Smith, Toby O, et al.
Publicado: (2021)

Post-traumatic stress disorder in patients with rheumatic disease during the COVID-19 outbreak: a cross-sectional case–control study in China
por: Wu, Xin, et al.
Publicado: (2022)

Patients’ experiences regarding self-monitoring of the disease course: an observational pilot study in patients with inflammatory rheumatic diseases at a rheumatology outpatient clinic in The Netherlands
por: Renskers, Lisanne, et al.
Publicado: (2020)

Adherence and dosing interval of subcutaneous antitumour necrosis factor biologics among patients with inflammatory arthritis: analysis from a Canadian administrative database
por: Bhoi, Peter, et al.
Publicado: (2017)

Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases
por: Silvagni, Ettore, et al.
Publicado: (2018)

Value of pulmonary artery pressure in predicting in-hospital and one-year mortality after valve replacement surgery in middle-aged and aged patients with rheumatic mitral disease: an observational study
por: Jiang, Lei, et al.
Publicado: (2017)

A randomised efficacy and discontinuation study of etanercept versus adalimumab (RED SEA) for rheumatoid arthritis: a pragmatic, unblinded, non-inferiority study of first TNF inhibitor use: outcomes over 2 years
por: Jobanputra, Paresh, et al.
Publicado: (2012)

Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial)
por: Uhrenholt, Line, et al.
Publicado: (2019)

Can the adherence to quality of care indicators for early rheumatoid arthritis in clinical practice reduce risk of hospitalisation? Retrospective cohort study based on the Record Linkage of Rheumatic Disease study of the Italian Society for Rheumatology
por: Zanetti, Anna, et al.
Publicado: (2020)

Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol
por: Teng, Y K Onno, et al.
Publicado: (2019)

Feasibility of delivering and evaluating stratified care integrated with telehealth (‘Rapid Stratified Telehealth’) for patients with low back pain: protocol for a feasibility and pilot randomised controlled trial
por: Zadro, Joshua R, et al.
Publicado: (2022)

A validation study of a new classification algorithm to identify rheumatoid arthritis using administrative health databases: case–control and cohort diagnostic accuracy studies. Results from the RECord linkage On Rheumatic Diseases study of the Italian Society for Rheumatology
por: Carrara, Greta, et al.
Publicado: (2015)

Treat-to-target strategy with secukinumab as a first-line biological disease modifying anti-rheumatic drug compared to standard-of-care treatment in patients with active axial spondyloarthritis: protocol for a randomised open-label phase III study, AScalate
por: Poddubnyy, Denis, et al.
Publicado: (2020)

COVID-19, rheumatic diseases and immune dysregulation—a perspective
por: Tariq, Shahna, et al.
Publicado: (2021)

Patterns of multimorbidity and their effects on adverse outcomes in rheumatoid arthritis: a study of 5658 UK Biobank participants
por: McQueenie, Ross, et al.
Publicado: (2020)

Challenges of caring for homeless patients with rheumatic and musculoskeletal disorders in Los Angeles
por: Seto, Richard, et al.
Publicado: (2020)

Different systemic rheumatic diseases as risk factors for COVID-19-related mortality
por: Fragoulis, George E., et al.
Publicado: (2022)

Real‐world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population‐based study
por: Rezende Macedo do Nascimento, Renata Cristina, et al.
Publicado: (2020)

Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis
por: Ooms, Alexander, et al.
Publicado: (2023)

Current State of Platelet-rich Plasma in the Treatment of Rheumatic Disease: A Retrospective Review of the Literature
por: Jacobs, Adam, et al.
Publicado: (2023)

Challenges in delivering rheumatology care during COVID-19 pandemic
por: Nune, A., et al.
Publicado: (2020)

Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseases
por: Oliveira Ramos, Filipa, et al.
Publicado: (2021)

Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses
por: Mehta, Pankti, et al.
Publicado: (2022)

Data Resource Profile: The Scottish National Prescribing Information System (PIS)
por: Alvarez-Madrazo, Samantha, et al.
Publicado: (2016)

Subcutaneous Abatacept in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis: Results From a Phase III Open‐Label Study
por: Brunner, Hermine I., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_58v5l2rmcplgh5r2lmik02ini8